- Company is committed to providing products based on formulations driven by solid scientific research
- Simply Sonoma is creating three tiers of products
- The company is developing products in four areas: the sleep aid market, the pain and inflammation sectors, the probiotic space, and the beauty and skin segments
In a CBD market becoming ever more crowded, Simply Sonoma is preparing to launch a line of CBD products that is truly distinctive. The company, which is also in the midst of a SEC regulation CF offering, is creating unique medicinal hemp strains that are alternatives to traditional, chemically manufactured offerings.
Specifically, the company is committed to providing products based on formulations driven by solid scientific research (https://cnw.fm/iX3r3). Simply Sonoma also works to educate consumers by providing relevant, timely information, including appropriate dosage levels. In addition, the company is looking beyond the traditional CBD offerings of gummies and tinctures, instead eyeing unique and different product options, such as CBD-infused organic apple juice and alcohol-free wine beverages.
Initially, Simply Sonoma is planning on three tiers of products: organic CBD formulations for consumer medicinal applications; organic whole-plant extracts of CBD and cannabinoids that provide the whole-plant synergistic effect and offer a dose response for a variety of diseases; and organic extracts paired with traditional over-the-counter functionality that are designed to deliver all the benefits of traditional OTC products but are organic and plant derived for a more natural healthy approach, minimizing synthetic chemical components and adverse effects.
In addition to its keen sensitivities to the most promising products, Simply Sonoma is also deeply aware of the best opportunities for growth and success. The company plans to develop products in four main areas: the global sleep aid market, which reached an estimated $175 billion last year; the joint and bone pain sectors, which are projected to top $41 billion by 2026; the probiotic space, which is forecast to reach $65 billion by 2023; and the beauty and skin segments, which totaled $380 billion in 2019. With its key differentiators already in place as a solid strategy backdrop, Simply Sonoma is projecting a five-year financial plan that shows gross revenues from these four segments reaching an estimated $15.5 million.
Those numbers can only strengthen the company’s CF offering, which notes that Simply Sonoma is laser focused on providing the purest, organically grown products possible. The company does this by using CBD obtained direct from the farm with as little processing and manipulation as possible. In addition, Simply Sonoma principals have years of farming experience, as well as a history as scientists in the biotech industry.
Simply Sonoma is a different kind of natural company. From seed to sale, it owns or contracts the organic grow, extraction and product formulation operations. The company has been developing products since 2017 based on scientific research and data and has several ready to launch. Its nationally available, organic CBD products utilize the company’s own unique formulations.
For more information or to invest in Simply Sonoma, visit the company’s website at www.SimplySonoma.org.
NOTE TO INVESTORS: The latest news and updates relating to Sonoma are available in the company’s newsroom at https://ibn.fm/Sonoma
About CannabisNewsWire
CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.
To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)
For more information please visit https://www.cannabisnewswire.com
Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer
Do you have questions or are you interested in working with CNW? Ask our Editor
CannabisNewsWire (CNW)
Denver, Colorado
www.cannabisnewswire.com
303.498.7722 Office
Editor@CannabisNewsWire.com
CannabisNewsWire is part of the InvestorBrandNetwork.
